These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 29683988)
1. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures. Yoo YJ; Han SB; Yang HK; Hwang JM Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988 [TBL] [Abstract][Full Text] [Related]
3. Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature. de Meel RHP; Raadsheer WF; van Zwet EW; Tannemaat MR; Verschuuren JJGM J Neuromuscul Dis; 2019; 6(3):369-376. PubMed ID: 31424417 [TBL] [Abstract][Full Text] [Related]
4. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Kupersmith MJ; Ying G Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126 [TBL] [Abstract][Full Text] [Related]
5. [Graves ophthalmopathy and ocular myasthenia]. Widjaja A; Rademaker J; Gölkel C; Holstein A; Leifke E; Wat N Ophthalmologe; 2000 Jan; 97(1):38-40. PubMed ID: 10663788 [TBL] [Abstract][Full Text] [Related]
6. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children. Mullaney P; Vajsar J; Smith R; Buncic JR Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889 [TBL] [Abstract][Full Text] [Related]
7. Diplopia in a patient presenting with "blurred vision": a case report. Harrison A; Mudhar O; Yoo J; Rampal M J Med Case Rep; 2023 Sep; 17(1):402. PubMed ID: 37679826 [TBL] [Abstract][Full Text] [Related]
8. Ocular myasthenia and nitrofurantoin. Wasserman BN; Chronister TE; Stark BI; Saran BR Am J Ophthalmol; 2000 Oct; 130(4):531-3. PubMed ID: 11024434 [TBL] [Abstract][Full Text] [Related]
9. Update on Ocular Myasthenia Gravis. Smith SV; Lee AG Neurol Clin; 2017 Feb; 35(1):115-123. PubMed ID: 27886889 [TBL] [Abstract][Full Text] [Related]
10. On the frontline: what an optometrist needs to know about myasthenia gravis. Pruitt JA; Ilsen PF Optometry; 2010 Sep; 81(9):454-60. PubMed ID: 20655284 [TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of thyroid associated ophthalmopathy with myasthenia Graves in 12 patients]. Ji H; Yang J; Zhu H; Jiang W; Sun F Zhonghua Yan Ke Za Zhi; 2015 Aug; 51(8):581-5. PubMed ID: 26696574 [TBL] [Abstract][Full Text] [Related]
16. Low-Density Lipoprotein Receptor-Related Protein 4-Positive Myasthenia Gravis in a Double-Seronegative, Electromyography-Negative Patient. Kruger JM; Karussis D; Zisimopoulou P; Petrou P J Neuroophthalmol; 2017 Sep; 37(3):285-286. PubMed ID: 28350570 [TBL] [Abstract][Full Text] [Related]
17. Update on Ocular Myasthenia Gravis. O'Hare M; Doughty C Semin Neurol; 2019 Dec; 39(6):749-760. PubMed ID: 31847046 [TBL] [Abstract][Full Text] [Related]
18. Pseudopartial Third Nerve Palsy as the Presenting Sign of Ocular Myasthenia Gravis. Bertolet AN; Druckenbrod RC Optom Vis Sci; 2020 May; 97(5):377-382. PubMed ID: 32413010 [TBL] [Abstract][Full Text] [Related]
19. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis. Akan O; Baysal-Kirac L Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450 [TBL] [Abstract][Full Text] [Related]
20. Inferior oblique muscle paresis as a sign of myasthenia gravis. Almog Y; Ben-David M; Nemet AY J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]